Stereotaxis
STXS
74 hedge funds and large institutions have $73.2M invested in Stereotaxis in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 18 reducing their positions, and 5 closing their positions.
2,450% more call options, than puts
Call options by funds: $51K | Put options by funds: $2K
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
33% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 18
13% more capital invested
Capital invested by funds: $64.9M → $73.2M (+$8.31M)
4% more funds holding
Funds holding: 71 → 74 (+3)
0.68% less ownership
Funds ownership: 48.28% → 47.6% (-0.68%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
Top Sellers
| 1 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
-$787K |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$727K |
| 3 |
E
Ergoteles
New York
|
-$293K |
| 4 |
GC
GMT Capital
Atlanta,
Georgia
|
-$228K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$160K |
STXS Hedge Fund Activity: Q4 2022 in Review
74 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Stereotaxis (STXS) for Q4 2022, worth a combined $73.2M — up 13% from $64.9M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new STXS positions and 5 closed out — a net gain of 4 holders — while 24 added to existing stakes and 18 trimmed.
The largest buyer was Lagoda Investment Management, adding an estimated $582K. The largest seller was Penn Capital Management, cutting an estimated $787K.
- 74 institutional investors held Stereotaxis (STXS) as of Q4 2022, up from 71 in Q3 2022.
- Funds reported $73.2M of Stereotaxis stock for Q4 2022, up 13% quarter-over-quarter.
- 9 funds opened new Stereotaxis positions in Q4 2022 and 5 closed out, a net change of +4 holders.
- The largest Stereotaxis buyer in Q4 2022 was Lagoda Investment Management, an estimated $582K added.
- The largest Stereotaxis seller in Q4 2022 was Penn Capital Management, an estimated $787K sold.
Based on aggregated 13F filings for Q4 2022.